These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 36870052
1. Establishment of a sequential dual tracer 18 F-NaF/18 F-FDG PET protocol for imaging the equine foot. Spriet M, Espinosa-Mur P, Zhang X, Berg E, Bec J, Katzman S, Galuppo L. Vet Radiol Ultrasound; 2023 May; 64(3):492-500. PubMed ID: 36870052 [Abstract] [Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med; 2019 May; 22(1):6-9. PubMed ID: 30843003 [Abstract] [Full Text] [Related]
3. Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy. Lin FI, Rao JE, Mittra ES, Nallapareddy K, Chengapa A, Dick DW, Gambhir SS, Iagaru A. Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):262-70. PubMed ID: 22065013 [Abstract] [Full Text] [Related]
4. 18 F-sodium fluoride positron emission tomography of the equine distal limb: Exploratory study in three horses. Spriet M, Espinosa P, Kyme AZ, Phillips KL, Katzman SA, Galuppo LD, Stepanov P, Beylin D. Equine Vet J; 2018 Jan; 50(1):125-132. PubMed ID: 28707737 [Abstract] [Full Text] [Related]
6. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer. Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A. J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167 [Abstract] [Full Text] [Related]
7. Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone. Sampath SC, Sampath SC, Mosci C, Lutz AM, Willmann JK, Mittra ES, Gambhir SS, Iagaru A. Clin Nucl Med; 2015 Mar; 40(3):e173-7. PubMed ID: 25140557 [Abstract] [Full Text] [Related]
8. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging. Minamimoto R, Mosci C, Jamali M, Barkhodari A, Habte F, Jackson T, Mittra E, Gambhir SS, Iagaru A. J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978 [Abstract] [Full Text] [Related]
11. Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by 18F-Fluoride and 18F-FDG. Li X, Heber D, Cal-Gonzalez J, Karanikas G, Mayerhoefer ME, Rasul S, Beitzke D, Zhang X, Agis H, Mitterhauser M, Wadsak W, Beyer T, Loewe C, Hacker M. J Nucl Med; 2017 Jun; 58(6):968-974. PubMed ID: 28232606 [Abstract] [Full Text] [Related]
12. 18 Fluorine-fluorodeoxyglucose positron emission tomography for assessment of deep digital flexor tendinopathy: An exploratory study in eight horses with comparison to CT and MRI. Wilson S, Spriet M, Mur PE, Anishchenko S, Beylin D, Katzman S, Galuppo L. Vet Radiol Ultrasound; 2021 Sep; 62(5):610-620. PubMed ID: 34148276 [Abstract] [Full Text] [Related]
13. Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients. Jackson T, Mosci C, von Eyben R, Mittra E, Ganjoo K, Biswal S, Gambhir SS, Iagaru A. Clin Nucl Med; 2015 Sep; 40(9):720-4. PubMed ID: 26053718 [Abstract] [Full Text] [Related]
14. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy. Guo J, Guo N, Lang L, Kiesewetter DO, Xie Q, Li Q, Eden HS, Niu G, Chen X. J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871 [Abstract] [Full Text] [Related]
15. 18 F-sodium fluoride positron emission tomography of the racing Thoroughbred fetlock: Validation and comparison with other imaging modalities in nine horses. Spriet M, Espinosa-Mur P, Cissell DD, Phillips KL, Arino-Estrada G, Beylin D, Stepanov P, Katzman SA, Galuppo LD, Garcia-Nolen T, Murphy B, Stover SM. Equine Vet J; 2019 May; 51(3):375-383. PubMed ID: 30218449 [Abstract] [Full Text] [Related]
16. Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT. Nakuz TS, Millinger FP, El-Rabadi K, Weber M, Pichler V, Wadsak W, Mitterhauser M, Haug A, Hacker M, Karanikas G, Pietschmann P, Agis H. Anticancer Res; 2019 Apr; 39(4):1943-1952. PubMed ID: 30952737 [Abstract] [Full Text] [Related]
17. Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer. Peterson LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, Jenkins I, Lee JH, Shields A, Montgomery S, Linden HM, Gralow J, Gadi VK, Muzi M, Kinahan P, Mankoff D, Specht JM. J Nucl Med; 2018 Dec; 59(12):1823-1830. PubMed ID: 29748233 [Abstract] [Full Text] [Related]